Neil William Aubuchon
Chief Commercial Officer, Viking Therapeutics.
Companies
- Viking TherapeuticsChief Commercial Officer Jan 26, 2026 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Viking Therapeutics VKTX4,475 shares2$112.4K at $25.11Mar 10, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 10, 2026Bought 4,475 shares at $33.50 of Viking Therapeutics2
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2